These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11699540)

  • 1. Attempts to stem Anthrax fears stumble.
    SoRelle R
    Circulation; 2001 Nov; 104(19):E9042-3. PubMed ID: 11699540
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846
    [No Abstract]   [Full Text] [Related]  

  • 5. From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    JAMA; 2001 Nov; 286(17):2086-8. PubMed ID: 11757496
    [No Abstract]   [Full Text] [Related]  

  • 6. From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    JAMA; 2001 Dec; 286(23):2935-6. PubMed ID: 11787481
    [No Abstract]   [Full Text] [Related]  

  • 7. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention
    JAMA; 2001 Nov; 286(19):2392-6. PubMed ID: 11759667
    [No Abstract]   [Full Text] [Related]  

  • 8. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related Anthrax--Connecticut, 2001.
    JAMA; 2002 Jan; 287(1):34-5. PubMed ID: 11797623
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
    Jernigan DB; Raghunathan PL; Bell BP; Brechner R; Bresnitz EA; Butler JC; Cetron M; Cohen M; Doyle T; Fischer M; Greene C; Griffith KS; Guarner J; Hadler JL; Hayslett JA; Meyer R; Petersen LR; Phillips M; Pinner R; Popovic T; Quinn CP; Reefhuis J; Reissman D; Rosenstein N; Schuchat A; Shieh WJ; Siegal L; Swerdlow DL; Tenover FC; Traeger M; Ward JW; Weisfuse I; Wiersma S; Yeskey K; Zaki S; Ashford DA; Perkins BA; Ostroff S; Hughes J; Fleming D; Koplan JP; Gerberding JL;
    Emerg Infect Dis; 2002 Oct; 8(10):1019-28. PubMed ID: 12396909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001.
    JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482
    [No Abstract]   [Full Text] [Related]  

  • 11. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Dec; 50(48):1077-9. PubMed ID: 11770501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthrax. Deadly delivery.
    Lemonick MD
    Time; 2001 Oct; 158(18):32-8. PubMed ID: 11682912
    [No Abstract]   [Full Text] [Related]  

  • 14. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and management of anthrax--an update.
    Swartz MN
    N Engl J Med; 2001 Nov; 345(22):1621-6. PubMed ID: 11704686
    [No Abstract]   [Full Text] [Related]  

  • 17. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey.
    Yetkin MA; Erdinc FS; Bulut C; Tulek N
    Saudi Med J; 2006 May; 27(5):737-9. PubMed ID: 16680276
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioterrorism threat becomes reality.
    Ready T
    Nat Med; 2001 Nov; 7(11):1167. PubMed ID: 11689863
    [No Abstract]   [Full Text] [Related]  

  • 20. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax, 2001.
    JAMA; 2001 Dec; 286(21):2662-3. PubMed ID: 11763854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.